German Federal Chancellor Scholz, WHO Director-General Dr Tedros and Bill Gates at the World Health Summit 2024
The world's leading global health conference begins on October 13.
(Berlin, Germany) – The financing of WHO, Germany's role in global health, antimicrobial resistance, Mpox, digitalization - topics like these are on the agenda of this year's World Health Summit from October 13-15 in Berlin. Leading international experts and decision-makers from all sectors will discuss strategies for a healthier future for all under the motto “Building Trust for a Healthier World”. Over 350 speakers and several thousand participants from all regions of the world are expected to attend, including numerous ministers, government officials and representatives from science, the private sector, civil society and international organizations.
The central event of the WHS 2024 is the presentation of the WHO Investment Round on Monday, October 14, 6:00 PM CEST. Confirmed speakers: German Chancellor Olaf Scholz, WHO Director-General Tedros Adhanom Ghebreyesus and Bill Gates, Chair of the Gates Foundation. The event “All for Health, Health for All: Signature Event for the WHO Investment Round” is being co-hosted by Germany, France and Norway as key supporters of the WHO Investment Round.
Media representatives can apply until October 9 for on-site accreditation at www.worldhealthsummit.org/media/accreditation.html.
The entire main program of the World Health Summit is open to the press.
The entire main program with over 60 sessions will also be available live online for free for people around the world who may not be able to attend in person at www.worldhealthsummit.org.
Press Kit:
www.worldhealthsummit.org/media/presskit.html
World Health Summit 2024
October 13 – 15
JW Marriott Hotel Berlin
Stauffenbergstraße 26, 10785 Berlin
www.worldhealthsummit.org
#WHS2024
X: @WorldHealthSmt
LinkedIn, Facebook, Instagram: @worldhealthsummit
Contacts
Christina Keppeler
Tel:+49 30 450 572102communications@worldhealthsummit.orgAbout news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Biomay Launches FDA-Grade CRISPR/Cas9 Nuclease for Off-the-Shelf Purchase9.5.2025 12:00:00 CEST | Press release
(Vienna, Austria) Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its off-the-shelf product portfolio for genome-editing applications. Clients purchasing Biomay´s Cas9 will benefit from the company´s unparalleled track record and expertise as a market-registered GMP-manufacturer of the nuclease. Biomay is the FDA-approved manufacturer of recombinant Cas9 as the essential component of CASGEVY®, the very first CRISPR genome editing product on the market. Biomay’s Cas9 (internal code “BMC9”) is based on the classical wild-type Cas9 nuclease from Streptococcus pyogenes. The Cas9 manufacturing process has been de novo developed, GMP-implemented and PPQ-validated by Biomay. GMP and RUO manufacturing is performed by fermentation with E. coli and by purification with chromatographic methods. By quality control with a comprehensive set of validated analytical assays, the consistent
mAInthink GmbH: Technological Breakthrough: Hallucination-Free Superintelligence Achieves 99.99% Strategic Accuracy – Germany Gains Permanent Strategic Superiority9.5.2025 10:57:00 CEST | Press release
Worms, May 9, 2025 – The mAInthink GmbH has achieved a technological breakthrough that redefines the future of strategic decision-making: With the development of StratePlan, a hallucination-free superintelligence delivering verified 99.99% strategic accuracy, Germany secures permanent technological, economic, and geopolitical superiority – operationally deployable and scientifically validated.
HEIDELBERG/Amperfied presents new DC fast charging solution with comprehensive range of services: Focus on dynamic power distribution and high availability7.5.2025 08:56:00 CEST | Press release
Offer is aimed at the increasing demand from charging parks, logistics depots and haulage fleets Amperfied addresses demand for fast charging system solutions with new DC product and performance-based offering DC becomes part of an availability-based operating hours model Modular technology for optimum utilization of the charging system and small footprint Debut at the Power2Drive 2025 Amperfied GmbH, a subsidiary of Heidelberger Druckmaschinen AG (HEIDELBERG), is entering the market for fast charging solutions complete with a comprehensive range of services. At the Power2Drive trade fair in Munich, the company will unveil its modular DC fast charging solution called Amperfied Dynamic DC, which focuses on availability and efficiency. The offering is aimed primarily at the growing demand from charging parks, logistics depots and haulage fleets for high-availability system solutions. This is because only with fast and functional charge points can charging infrastructure operators (CPOs)
HEIDELBERG holds its ground in a difficult market environment in FY 2024/25 - targets achieved, significant increase in incoming orders compared to previous year6.5.2025 08:52:59 CEST | Press release
Sales and adjusted EBITDA margin at previous year's level according to preliminary figures Free cash flow excluding special items clearly positive at around € 50 million Rising order intake compared to previous year lays the foundation for a good start to FY 2025/26 Additional, positive order impetus expected from China Print trade fair in May Adjusted EBITDA margin to rise to around 8 percent in FY 2025/26
eM Client version 10.3 adds features familiar from Postbox5.5.2025 13:32:56 CEST | Press release
Prague – 05.05.2025 - The Czech company eM Client has launched a new version of its eponymous email application, positioning their software as the primary rival to Microsoft Outlook in the email app market. The most recent release, version 10.3, also incorporates the most popular features from Postbox, an email application developed by Postbox Inc., which has ceased operations and was acquired by eM Client in 2024.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom